Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Lymphocytes may hinder hair stem cells, causing hair loss without scarring.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

Topical treatments and skin care improve transplant-related atopic dermatitis in children.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

IL-26 has antimicrobial and pro-inflammatory effects in the chronic skin condition Hidradenitis Suppurativa.

Erosive pustular dermatosis is a rare skin disease that's hard to treat and affects the scalp or legs.

The pony's skin condition improved significantly with prednisolone treatment.

Severe alopecia areata may increase the risk of hidden artery disease.

MicroRNAs could help assess and manage multiple chronic diseases.

Histone modification is key in treating chronic inflammatory skin diseases.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Stress, nutritional issues, and chronic diseases can cause hair loss, and nail changes may signal internal diseases; treatment focuses on the underlying cause.

Higher IL-31 levels are linked to worse itching in chronic kidney disease patients.

Elderly people, especially with chronic conditions, are more at risk of severe COVID-19 complications and need preventive care and social support.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

People with Parkinson's disease have higher levels of cortisone in their hair, which may indicate chronic stress hormone dysfunction.

Exclamation mark hairs suggest early scalp disease, while white dots indicate it's chronic.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

The document concludes that various skin conditions have specific treatments, ranging from antihistamines for urticaria to surgery and medication for tumors and chronic skin diseases.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Sheep with chronic Sarcoptes scabiei dermatitis have altered keratin expression in their skin.

Bioprinting is improving skin models for better testing of skin diseases without using animals.